Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Bill Kelly

Achillion reports enrollments in two trials

Achillion reports that it achieved threshold enrollment in the Phase 2 trials of ACH-4471 for patients with C3 glomerulopathy (C3G), a devastating disease affecting the...

| By Bill Kelly

Branford-based ViiV’s Dovato wins FDA approval

GSK’s ViiV secured FDA approval for Dovato after submitting a marketing application with a priority review voucher (PRV) last October. The drug is used to treat...

| By Bill Kelly

UConn teams up to create stem cell biobank

A new collaboration between UConn Health and the Foundation for Prader-Willi Research will create a centralized, high quality biobank of stem cells to help researchers...

| By Bill Kelly

NSF grant supports Azitra’s Netherton treatment

Azitra has been awarded a Phase II Small Business Innovation Research (SBIR) grant (#1853071) of $719,700 from the National Science Foundation (NSF). This grant will support...

| By Bill Kelly

BioCT welcomes new member Tangen Biosciences

Tangen Biosciences was founded in 2013 and is located in Branford, Connecticut. The Company has developed an innovative platform that enables molecular diagnostic technology to...

| By Bill Kelly

UNH surpasses centennial fundraising goal

The University of New Haven has announced that its first-ever comprehensive fundraising campaign has surpassed its original goal of $100 million. The ambitious nine-figure target,...

| By Bill Kelly

SpringWorks completes $125 million Series B

SpringWorks Therapeutics reports the closing of a $125 million Series B preferred stock financing led by Perceptive Advisors. Proceeds from the financing will be used to...